BioControl develops advanced active implantable medical devices for the treatment of autonomic disorders, conditions whereby the autonomic nervous system ceases to function properly, resulting in a disruption to the control of involuntary body processes. The devices enable controlled electrical stimulation of various nerves to achieve therapeutic results.
BioControl has developed the CardioFit(r) System, intended to effectively treat heart failure via vagus nerve stimulation. It has received the CE mark (2008) and is available in the U.S. under Investigational Device Exemption.
|
|
|
|
|
11-50 employees
View all BioControl Medical employees
|
|
|
Medical Equipment Manufacturing
|
|
|
$10M–$50M
|
|
|
+1-612-555-0199
|
|
|
Minneapolis, Minnesota, USA
|
|
|
1999
|
|
|
Active Implantable Devices
|
BioControl Medical headquarters is located at Minneapolis, Minnesota, USA.
BioControl Medical generates an estimated $5M–$20M annually, based on industry analysis and publicly available market data.
You can contact BioControl Medical by calling +1-612-555-0199.
BioControl Medical headquarters is located at Minneapolis, Minnesota, USA.
BioControl Medical generates an estimated $10M–$50M annually, based on industry analysis and publicly available market data.
You can contact BioControl Medical by calling +1-612-555-0199.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.